I. Introduction
Embryonal central nervous system (CNS) tumours are a diverse group of diseases that constitute the most common group of malignant brain tumours in childhood. Brain tumors are classified according to histology, but tumor location and extent of spread are important factors that affect treatment and prognosis. Immunohistochemical analysis, cytogenetic and molecular genetic findings, as well as measures of mitotic activity, have been used in tumor diagnosis and classification (e.g. [1], [2], [3], [4], [5], [6]). Each year, nearly 3,000 children in the U.S. are diagnosed with brain tumors. Almost half will die within five years, making it the most fatal cancer among children. If a child does survive a brain tumor, the long-term effects can be significant and can include neurological disabilities, retardation and psychological problems [7]. Beyond surgery, successful treatments for childhood brain tumors are rare.